Current Signal Transduction Therapy

Editor-in-Chief

Jingxuan Yang
The University of Oklahoma Health Science Center
Oklahoma City, OK
(USA)

Back

Become EABM
Become Reviewer

Targeting Neurotrophic Signal Transduction Pathways in the Treatment of Mood Disorders

Volume:2   Issue: 2
Pp: 101-110
Todd D. Gould and Husseini K. Manji
DOI: 10.2174/157436207780619518

Smad-Signaling in Mammary Gland Development and Tumorigenesis

Volume:2   Issue: 2
Pp: 111-120
Vandana Gupta, Arunthathi Thiagalingam and Shyamala Maheswaran
DOI: 10.2174/157436207780619482

Nitric Oxide: Friendly Rivalry in Tuberculosis

Volume:2   Issue: 2
Pp: 121-128
Sangita Mukhopadhyay, Shiny Nair and Seyed E. Hasnain
DOI: 10.2174/157436207780619536

Potential Utilization of Bystander / Abscopal-Mediated Signal Transduction Events in the Treatment of Solid Tumors

Volume:2   Issue: 2
Pp: 129-143
Matthew E. Peters, Mohammed M. Shareef, Seema Gupta, Marianna Zagurovskaya-Sultanov, Munira Kadhim, Mohammed Mohiuddin and Mansoor M. Ahmed
DOI: 10.2174/157436207780619509

Oncogene-Directed Therapies as Modulators of Cancer Coagulopathy, Angiogenesis and Tumor-Vascular Interface

Volume:2   Issue: 2
Pp: 157-163
Janusz Rak, Chloe Milsom, Linda May and Joanne Yu
DOI: 10.2174/157436207780619473

Molecular Rationales for Signal Transduction Therapy and Chemoprevention of BRCA1-Related Breast and Ovarian Tumours

Volume:2   Issue: 2
Pp: 165-173
P. Tagliaferri, P. Tassone, A. Pietragalla, M. S. Rotundo, V. Barbieri, A. Budillon, M. Caraglia, F. S. Costanzo and S. Venuta
DOI: 10.2174/157436207780619491

Blocking Apoptotic Intracellular Signaling Cascades with Cell-Permeable Peptides

Volume:2   Issue: 2
Pp: 175-179
Azel Zine, Alain Uziel, Jacques Beckmann and Christophe Bonny
DOI: 10.2174/157436207780619527